Regulation
FDA greenlights Rivanna’s AI musculoskeletal imaging system
The FDA has cleared Rivanna's Accuro XV system, an AI-enabled musculoskeletal imaging platform. The company plans to accelerate development of additional AI capabilities for the system following the clearance.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network